Body,Head,Head_Coverage,Std_Confidence,PCA_Confidence,Positive_Examples,Body_size,PCA_Body_size,Functional_variable
?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.019414049,0.93220339,0.93220339,55,59,59,?a
?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.018708083,0.946428571,0.946428571,53,56,56,?a
?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.018708083,0.913793103,0.913793103,53,58,58,?a
?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.018708083,0.757142857,0.815384615,53,70,65,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.039534063,0.817518248,0.817518248,112,137,137,?a
?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.018708083,0.898305085,0.898305085,53,59,59,?a
?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.018002118,0.910714286,0.910714286,51,56,56,?a
?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.018002118,0.879310345,0.879310345,51,58,58,?a
?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.064948818,0.915422886,0.915422886,184,201,201,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.075538299,0.772563177,0.772563177,214,277,277,?a
?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.020120014,0.814285714,0.876923077,57,70,65,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.129544652,0.74291498,0.74291498,367,494,494,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.013413343,0.775510204,0.791666667,38,49,48,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.022590893,0.703296703,0.703296703,64,91,91,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.010942464,0.756097561,0.756097561,31,41,41,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.025061772,0.731958763,0.731958763,71,97,97,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.010236498,0.725,0.763157895,29,40,38,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.011648429,0.66,0.70212766,33,50,47,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.019414049,0.948275862,0.948275862,55,58,58,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.018708083,0.963636364,0.963636364,53,55,55,?a
?a  hasStage  IV  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.012707377,0.818181818,0.818181818,36,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.015531239,0.956521739,0.956521739,44,46,46,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.017649135,0.943396226,0.943396226,50,53,53,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.017649135,0.943396226,0.943396226,50,53,53,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.010236498,0.966666667,0.966666667,29,30,30,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.018708083,0.929824561,0.929824561,53,57,57,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.01694317,0.941176471,0.941176471,48,51,51,?a
?a  hasGender  Female  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.015178256,0.955555556,0.955555556,43,45,45,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.010942464,0.96875,0.96875,31,32,32,?a
?a  hasGender  Female  ?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.015178256,0.977272727,0.977272727,43,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.012707377,0.972972973,0.972972973,36,37,37,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.017649135,0.877192982,0.877192982,50,57,57,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.010236498,0.878787879,0.878787879,29,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.011648429,0.846153846,0.916666667,33,39,36,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.011648429,0.825,0.868421053,33,40,38,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.010589481,0.810810811,0.857142857,30,37,35,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.013766325,0.764705882,0.764705882,39,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.021178962,0.638297872,0.731707317,60,94,82,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.028238616,0.655737705,0.740740741,80,122,108,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.015884222,0.737704918,0.737704918,45,61,61,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.015531239,0.771929825,0.771929825,44,57,57,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.015884222,0.661764706,0.725806452,45,68,62,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.015531239,0.771929825,0.8,44,57,55,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.03000353,0.867346939,0.867346939,85,98,98,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.015178256,0.728813559,0.728813559,43,59,59,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.023296858,0.891891892,0.891891892,66,74,74,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.019414049,0.662650602,0.763888889,55,83,72,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.013413343,0.678571429,0.745098039,38,56,51,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.018355101,0.634146341,0.764705882,52,82,68,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.017296152,0.742424242,0.765625,49,66,64,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.017296152,0.765625,0.765625,49,64,64,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.022590893,0.853333333,0.853333333,64,75,75,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.014825274,0.724137931,0.724137931,42,58,58,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.016590187,0.661971831,0.734375,47,71,64,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.023296858,0.814814815,0.814814815,66,81,81,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.012354395,0.68627451,0.7,35,51,50,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.013413343,0.703703704,0.703703704,38,54,54,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.021884928,0.729411765,0.729411765,62,85,85,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.010942464,0.673913043,0.720930233,31,46,43,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.012707377,0.72,0.734693878,36,50,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.010942464,0.574074074,0.720930233,31,54,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.011648429,0.66,0.70212766,33,50,47,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.01306036,0.755102041,0.755102041,37,49,49,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.021884928,0.738095238,0.746987952,62,84,83,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.017649135,0.819672131,0.819672131,50,61,61,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.038828097,0.820895522,0.820895522,110,134,134,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.015531239,0.897959184,0.897959184,44,49,49,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.017296152,0.830508475,0.830508475,49,59,59,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.019414049,0.723684211,0.723684211,55,76,76,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.013413343,0.863636364,0.863636364,38,44,44,?a
?a  hasStage  IIIB  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.011648429,0.825,0.825,33,40,40,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.018002118,0.879310345,0.879310345,51,58,58,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.025767737,0.858823529,0.858823529,73,85,85,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.017649135,0.877192982,0.877192982,50,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.030356513,0.851485149,0.851485149,86,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.01306036,0.860465116,0.860465116,37,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.015531239,0.88,0.88,44,50,50,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.027885634,0.822916667,0.822916667,79,96,96,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.015178256,0.716666667,0.716666667,43,60,60,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.011648429,0.647058824,0.717391304,33,51,46,?a
?a  hasStage  IIIB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.010236498,0.805555556,0.805555556,29,36,36,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.010589481,0.810810811,0.810810811,30,37,37,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.013413343,0.76,0.76,38,50,50,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.012354395,0.564516129,0.7,35,62,50,?a
?a  hasStage  IV  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.027179668,0.927710843,0.927710843,77,83,83,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.042357924,0.603015075,0.701754386,120,199,171,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.013413343,0.844444444,0.844444444,38,45,45,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.021531945,0.824324324,0.824324324,61,74,74,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.026826685,0.684684685,0.745098039,76,111,102,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.010942464,0.704545455,0.704545455,31,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.020120014,0.919354839,0.919354839,57,62,62,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.017296152,0.924528302,0.924528302,49,53,53,?a
?a  hasGender  Female  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.015178256,0.955555556,0.955555556,43,45,45,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.011648429,0.942857143,0.942857143,33,35,35,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.017649135,0.925925926,0.925925926,50,54,54,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.012001412,0.971428571,0.971428571,34,35,35,?a
?a  hasGender  Female  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.014825274,0.954545455,0.954545455,42,44,44,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.01694317,0.923076923,0.923076923,48,52,52,?a
?a  hasGender  Female  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.015178256,0.934782609,0.934782609,43,46,46,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.012001412,0.918918919,0.918918919,34,37,37,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.013766325,0.764705882,0.764705882,39,51,51,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.010589481,0.731707317,0.731707317,30,41,41,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.019767031,0.708860759,0.708860759,56,79,79,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.014472291,0.82,0.82,41,50,50,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.05224144,0.778947368,0.778947368,148,190,190,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.024002824,0.390804598,0.708333333,68,174,96,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.017649135,0.704225352,0.769230769,50,71,65,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.093187434,0.745762712,0.745762712,264,354,354,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.010589481,0.967741935,0.967741935,30,31,31,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.036357218,0.927927928,0.927927928,103,111,111,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.017649135,0.943396226,0.943396226,50,53,53,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.038475115,0.923728814,0.923728814,109,118,118,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.046240734,0.922535211,0.922535211,131,142,142,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.046593717,0.809815951,0.809815951,132,163,163,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.014472291,0.788461538,0.788461538,41,52,52,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.015178256,0.86,0.86,43,50,50,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.040240028,0.797202797,0.797202797,114,143,143,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.017649135,0.793650794,0.793650794,50,63,63,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.021531945,0.835616438,0.835616438,61,73,73,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.055065302,0.783919598,0.783919598,156,199,199,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.010236498,0.852941176,0.852941176,29,34,34,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.053300388,0.751243781,0.751243781,151,201,201,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.016237204,0.469387755,0.779661017,46,98,59,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.030709495,0.731092437,0.763157895,87,119,114,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.011648429,0.846153846,0.916666667,33,39,36,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015531239,0.830188679,0.830188679,44,53,53,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.010236498,0.878787879,0.878787879,29,33,33,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.031415461,0.787610619,0.787610619,89,113,113,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.038475115,0.756944444,0.756944444,109,144,144,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.012354395,0.660377358,0.744680851,35,53,47,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.067066714,0.76,0.76,190,250,250,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.01694317,0.705882353,0.705882353,48,68,68,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.013413343,0.703703704,0.703703704,38,54,54,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.04835863,0.752747253,0.752747253,137,182,182,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.012707377,0.75,0.75,36,48,48,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.012001412,0.85,0.894736842,34,40,38,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.01306036,0.649122807,0.725490196,37,57,51,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.016590187,0.796610169,0.796610169,47,59,59,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.015178256,0.682539683,0.716666667,43,63,60,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.025061772,0.371727749,0.717171717,71,191,99,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.094246382,0.787610619,0.787610619,267,339,339,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.015178256,0.754385965,0.754385965,43,57,57,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Carboplatin,0.014119308,0.64516129,0.727272727,40,62,55,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.067408377,0.903508772,0.903508772,103,114,114,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.031413613,0.96,0.96,48,50,50,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022905759,0.564516129,0.729166667,35,62,48,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.027486911,0.84,0.84,42,50,50,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.087041885,0.269230769,0.707446809,133,494,188,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ALK_Negative,0.066753927,0.894736842,0.894736842,102,114,114,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.060863874,0.704545455,0.704545455,93,132,132,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.193062827,0.754475703,0.754475703,295,391,391,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.030104712,0.92,0.92,46,50,50,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.144633508,0.891129032,0.891129032,221,248,248,?a
?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.043848168,0.558333333,0.72826087,67,120,92,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.039921466,0.628865979,0.7625,61,97,80,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.045811518,0.307017544,0.714285714,70,228,98,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.026832461,0.661290323,0.854166667,41,62,48,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.092931937,0.596638655,0.720812183,142,238,197,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.130235602,0.325163399,0.728937729,199,612,273,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.096204188,0.29757085,0.781914894,147,494,188,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.068062827,0.912280702,0.912280702,104,114,114,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.875,0.875,28,32,32,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Negative,0.193062827,0.833333333,0.833333333,295,354,354,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.029450262,0.9,0.9,45,50,50,?a
?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.181282723,0.318390805,0.760989011,277,870,364,?a
?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.02552356,0.276595745,0.722222222,39,141,54,?a
?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.079842932,0.425087108,0.730538922,122,287,167,?a
?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.054319372,0.342975207,0.754545455,83,242,110,?a
?a  hasStage  IB   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.168421053,0.8,16,95,20,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.140052356,0.862903226,0.862903226,214,248,248,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.271186441,0.842105263,16,59,19,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.05104712,0.342105263,0.795918367,78,228,98,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.05104712,0.21971831,0.75,78,355,104,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.364963504,0.724637681,50,137,69,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.333333333,0.757575758,50,150,66,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.132853403,0.410931174,0.719858156,203,494,282,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.039921466,0.516949153,0.743902439,61,118,82,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.066099476,0.537234043,0.706293706,101,188,143,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.02617801,0.64516129,0.833333333,40,62,48,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.040575916,0.639175258,0.775,62,97,80,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.086387435,0.494382022,0.809815951,132,267,163,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  EGFR_Negative,0.013089005,0.266666667,0.8,20,75,25,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.026832461,0.166666667,0.803921569,41,246,51,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.106020942,0.680672269,0.822335025,162,238,197,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.070026178,0.386281588,0.727891156,107,277,147,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022251309,0.548387097,0.708333333,34,62,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.035340314,0.805970149,0.805970149,54,67,67,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.030759162,0.770491803,0.770491803,47,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.017015707,0.530612245,0.702702703,26,49,37,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.017015707,0.742857143,0.742857143,26,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.026832461,0.976190476,0.976190476,41,42,42,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.05039267,0.905882353,0.905882353,77,85,85,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.031413613,0.941176471,0.941176471,48,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.062827225,0.941176471,0.941176471,96,102,102,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.020287958,0.939393939,0.939393939,31,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.052356021,0.930232558,0.930232558,80,86,86,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.018979058,0.90625,0.90625,29,32,32,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.022251309,0.918918919,0.918918919,34,37,37,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.062172775,0.913461538,0.913461538,95,104,104,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.028141361,0.934782609,0.934782609,43,46,46,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.02552356,0.928571429,0.928571429,39,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.029450262,0.703125,0.703125,45,64,64,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.010471204,0.941176471,0.941176471,16,17,17,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.017670157,0.529411765,0.771428571,27,51,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.016361257,0.925925926,0.925925926,25,27,27,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.012434555,0.678571429,0.904761905,19,28,21,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.039921466,0.910447761,0.910447761,61,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.029450262,0.97826087,0.97826087,45,46,46,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.020942408,0.727272727,0.727272727,32,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  ROS1_Negative,0.014397906,0.733333333,0.733333333,22,30,30,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.033376963,0.728571429,0.728571429,51,70,70,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.051701571,0.849462366,0.849462366,79,93,93,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.020287958,0.756097561,0.756097561,31,41,41,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.046465969,0.724489796,0.724489796,71,98,98,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.023560209,0.72,0.72,36,50,50,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.02486911,0.791666667,0.791666667,38,48,48,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.020942408,0.780487805,0.780487805,32,41,41,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.04973822,0.863636364,0.863636364,76,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.010471204,0.941176471,0.941176471,16,17,17,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.019633508,0.789473684,0.789473684,30,38,38,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.012434555,0.703703704,0.703703704,19,27,27,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.02486911,0.703703704,0.703703704,38,54,54,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.014397906,0.814814815,0.814814815,22,27,27,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.02617801,0.701754386,0.701754386,40,57,57,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.027486911,0.976744186,0.976744186,42,43,43,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.022905759,0.972222222,0.972222222,35,36,36,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.018324607,0.823529412,0.823529412,28,34,34,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.028795812,0.977777778,0.977777778,44,45,45,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.020942408,0.96969697,0.96969697,32,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.018979058,0.707317073,0.707317073,29,41,41,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.033376963,0.962264151,0.962264151,51,53,53,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ROS1_Negative,0.020287958,0.96875,0.96875,31,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.020287958,0.775,0.775,31,40,40,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.018979058,0.659090909,0.743589744,29,44,39,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.013089005,0.571428571,0.8,20,35,25,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.02617801,0.540540541,0.740740741,40,74,54,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.015052356,0.676470588,0.766666667,23,34,30,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.018979058,0.783783784,0.828571429,29,37,35,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.012434555,0.703703704,0.791666667,19,27,24,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.013743455,0.538461538,0.807692308,21,39,26,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.015706806,0.615384615,0.75,24,39,32,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.014397906,0.88,0.88,22,25,25,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.02617801,0.869565217,0.869565217,40,46,46,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.02552356,0.866666667,0.866666667,39,45,45,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.026832461,0.854166667,0.854166667,41,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.020287958,0.939393939,0.939393939,31,33,33,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.020942408,0.888888889,0.888888889,32,36,36,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  BRAF_Negative,0.012434555,0.904761905,0.904761905,19,21,21,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.014397906,0.916666667,0.916666667,22,24,24,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.011125654,0.944444444,0.944444444,17,18,18,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.012434555,0.904761905,0.904761905,19,21,21,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.02486911,0.716981132,0.716981132,38,53,53,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.10013089,0.768844221,0.768844221,153,199,199,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.02421466,0.192708333,0.711538462,37,192,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.018324607,0.549019608,0.8,28,51,35,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.034685864,0.389705882,0.706666667,53,136,75,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.02486911,0.678571429,0.775510204,38,56,49,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.011780105,0.642857143,0.857142857,18,28,21,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.048429319,0.643478261,0.762886598,74,115,97,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.032068063,0.907407407,0.907407407,49,54,54,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.02552356,0.735849057,0.735849057,39,53,53,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.015706806,0.96,0.96,24,25,25,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.054319372,0.922222222,0.922222222,83,90,90,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.350877193,0.833333333,20,57,24,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.054973822,0.258461538,0.717948718,84,325,117,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.079188482,0.823129252,0.823129252,121,147,147,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.028141361,0.260606061,0.728813559,43,165,59,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.183333333,0.75862069,22,120,29,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.021596859,0.34375,0.868421053,33,96,38,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.031413613,0.340425532,0.761904762,48,141,63,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.017670157,0.551020408,0.72972973,27,49,37,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.022251309,0.336633663,0.871794872,34,101,39,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.036649215,0.918032787,0.918032787,56,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.039921466,0.239215686,0.726190476,61,255,84,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.013743455,0.344262295,0.777777778,21,61,27,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.035340314,0.947368421,0.947368421,54,57,57,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.017015707,0.742857143,0.742857143,26,35,35,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.030759162,0.412280702,0.770491803,47,114,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.571428571,0.769230769,20,35,26,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.013743455,0.677419355,0.875,21,31,24,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.02486911,0.361904762,0.730769231,38,105,52,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.012434555,0.28358209,0.76,19,67,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.019633508,0.909090909,0.909090909,30,33,33,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.769230769,0.769230769,20,26,26,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011125654,0.85,0.85,17,20,20,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.036649215,0.622222222,0.777777778,56,90,72,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.020287958,0.885714286,0.885714286,31,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.022251309,0.918918919,0.918918919,34,37,37,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.02617801,0.952380952,0.952380952,40,42,42,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.062827225,0.932038835,0.932038835,96,103,103,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.017670157,0.964285714,0.964285714,27,28,28,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.015052356,0.92,0.92,23,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.022905759,0.897435897,0.897435897,35,39,39,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.016361257,0.925925926,0.925925926,25,27,27,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.010471204,0.941176471,0.941176471,16,17,17,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.015706806,0.96,0.96,24,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.012434555,0.95,0.95,19,20,20,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.04973822,0.863636364,0.863636364,76,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.027486911,0.777777778,0.777777778,42,54,54,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.015052356,0.92,0.92,23,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.02486911,0.904761905,0.904761905,38,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.02421466,0.770833333,0.770833333,37,48,48,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.021596859,0.804878049,0.804878049,33,41,41,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.015052356,0.71875,0.71875,23,32,32,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.028795812,0.771929825,0.771929825,44,57,57,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.030104712,0.754098361,0.754098361,46,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.035994764,0.705128205,0.705128205,55,78,78,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.769230769,0.769230769,20,26,26,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.740740741,0.740740741,20,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.023560209,0.87804878,0.87804878,36,41,41,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.034031414,0.764705882,0.764705882,52,68,68,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.022251309,0.894736842,0.894736842,34,38,38,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.019633508,0.882352941,0.882352941,30,34,34,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.028141361,0.716666667,0.716666667,43,60,60,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.027486911,0.933333333,0.933333333,42,45,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.034685864,0.85483871,0.85483871,53,62,62,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.032722513,0.819672131,0.819672131,50,61,61,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.132853403,0.763157895,0.763157895,203,266,266,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.140706806,0.776173285,0.776173285,215,277,277,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.039267016,0.769230769,0.769230769,60,78,78,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.032722513,0.943396226,0.943396226,50,53,53,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.039267016,0.789473684,0.789473684,60,76,76,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.056282723,0.851485149,0.851485149,86,101,101,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.023560209,0.9,0.9,36,40,40,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.038612565,0.756410256,0.756410256,59,78,78,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.020287958,0.939393939,0.939393939,31,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.053010471,0.757009346,0.757009346,81,107,107,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.088350785,0.780346821,0.780346821,135,173,173,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.02617801,0.754716981,0.754716981,40,53,53,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.02552356,0.78,0.78,39,50,50,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.769230769,0.833333333,20,26,24,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.029450262,0.9375,0.9375,45,48,48,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.039921466,0.953125,0.953125,61,64,64,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.916666667,0.916666667,22,24,24,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.033376963,0.944444444,0.944444444,51,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.101439791,0.901162791,0.901162791,155,172,172,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.02486911,0.95,0.95,38,40,40,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.098167539,0.903614458,0.903614458,150,166,166,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.048429319,0.891566265,0.891566265,74,83,83,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.012434555,0.542857143,0.76,19,35,25,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.046465969,0.91025641,0.91025641,71,78,78,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.019633508,0.810810811,0.857142857,30,37,35,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.067408377,0.903508772,0.903508772,103,114,114,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.021596859,0.916666667,0.916666667,33,36,36,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.064790576,0.891891892,0.891891892,99,111,111,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.027486911,0.567567568,0.777777778,42,74,54,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.952380952,0.952380952,20,21,21,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.022905759,0.507246377,0.729166667,35,69,48,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.020287958,0.704545455,0.794871795,31,44,39,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.015052356,0.676470588,0.766666667,23,34,30,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.030759162,0.194214876,0.734375,47,242,64,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.028141361,0.632352941,0.767857143,43,68,56,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.02617801,0.266666667,0.714285714,40,150,56,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.023560209,0.321428571,0.734693878,36,112,49,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.035340314,0.315789474,0.794117647,54,171,68,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.061518325,0.606451613,0.752,94,155,125,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.021596859,0.673469388,0.70212766,33,49,47,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.015052356,0.58974359,0.884615385,23,39,26,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.017015707,0.896551724,0.896551724,26,29,29,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.018324607,0.682926829,0.736842105,28,41,38,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ALK_Negative,0.015706806,0.137931034,0.705882353,24,174,34,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.019633508,0.454545455,0.731707317,30,66,41,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.02617801,0.487804878,0.740740741,40,82,54,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.021596859,0.6,0.717391304,33,55,46,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.011780105,0.352941176,0.72,18,51,25,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.227272727,0.714285714,20,88,28,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.016361257,0.384615385,0.735294118,25,65,34,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.010471204,0.761904762,0.8,16,21,20,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.02552356,0.672413793,0.75,39,58,52,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.010471204,0.484848485,0.761904762,16,33,21,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.011125654,0.459459459,0.80952381,17,37,21,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.015706806,0.571428571,0.727272727,24,42,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.043193717,0.554621849,0.741573034,66,119,89,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.018979058,0.391891892,0.725,29,74,40,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.023560209,0.342857143,0.734693878,36,105,49,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.013089005,0.434782609,0.740740741,20,46,27,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.628571429,0.916666667,22,35,24,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.023560209,0.666666667,0.8,36,54,45,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.029450262,0.803571429,0.882352941,45,56,51,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.020942408,0.64,0.8,32,50,40,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.037958115,0.651685393,0.783783784,58,89,74,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.060209424,0.621621622,0.741935484,92,148,124,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.031413613,0.685714286,0.813559322,48,70,59,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.020942408,0.507936508,0.727272727,32,63,44,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.022905759,0.673076923,0.777777778,35,52,45,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.037958115,0.644444444,0.773333333,58,90,75,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.020287958,0.525423729,0.704545455,31,59,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.02552356,0.428571429,0.735849057,39,91,53,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.47826087,0.733333333,22,46,30,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.423076923,0.75862069,22,52,29,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.020287958,0.553571429,0.720930233,31,56,43,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.014397906,0.666666667,0.916666667,22,33,24,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.056282723,0.577181208,0.728813559,86,149,118,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.043848168,0.492647059,0.770114943,67,136,87,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.028795812,0.366666667,0.8,44,120,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.029450262,0.234375,0.865384615,45,192,52,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.107329843,0.346723044,0.780952381,164,473,210,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.10013089,0.85,0.85,153,180,180,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.073298429,0.875,0.875,112,128,128,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.022905759,0.564516129,0.744680851,35,62,47,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.035994764,0.404411765,0.733333333,55,136,75,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.017015707,0.288888889,0.742857143,26,90,35,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.017670157,0.375,0.84375,27,72,32,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.02617801,0.714285714,0.816326531,40,56,49,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.022905759,0.538461538,0.760869565,35,65,46,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.041884817,0.503937008,0.831168831,64,127,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.327272727,0.818181818,36,110,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.054973822,0.730434783,0.865979381,84,115,97,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.073298429,0.448,0.736842105,112,250,152,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.181102362,0.92,23,127,25,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.079188482,0.909774436,0.909774436,121,133,133,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.011780105,0.642857143,0.857142857,18,28,21,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.054973822,0.933333333,0.933333333,84,90,90,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.02486911,0.342342342,0.844444444,38,111,45,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.066753927,0.288951841,0.816,102,353,125,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.336633663,0.871794872,34,101,39,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.034685864,0.981481481,0.981481481,53,54,54,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.030759162,0.284848485,0.796610169,47,165,59,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.191666667,0.793103448,23,120,29,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.061518325,0.289230769,0.803418803,94,325,117,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.026832461,0.39047619,0.788461538,41,105,52,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.014397906,0.360655738,0.814814815,22,61,27,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.022905759,0.364583333,0.921052632,35,96,38,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.036649215,0.835820896,0.835820896,56,67,67,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.013743455,0.368421053,0.875,21,57,24,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.035994764,0.48245614,0.901639344,55,114,61,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.011125654,0.85,0.85,17,20,20,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.041230366,0.7,0.875,63,90,72,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.020287958,0.885714286,0.885714286,31,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.020287958,0.939393939,0.939393939,31,33,33,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.714285714,0.714285714,25,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.918918919,0.918918919,34,37,37,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.02552356,0.928571429,0.928571429,39,42,42,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.92,0.92,23,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.062172775,0.922330097,0.922330097,95,103,103,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.051701571,0.918604651,0.918604651,79,86,86,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Negative,0.011125654,0.944444444,0.944444444,17,18,18,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.02617801,0.952380952,0.952380952,40,42,42,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.051701571,0.929411765,0.929411765,79,85,85,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.015706806,0.96,0.96,24,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.028141361,0.934782609,0.934782609,43,46,46,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.933333333,0.933333333,28,30,30,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.053010471,0.861702128,0.861702128,81,94,94,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.925925926,0.925925926,25,27,27,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.051701571,0.840425532,0.840425532,79,94,94,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.039267016,0.857142857,0.857142857,60,70,70,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.019633508,0.9375,0.9375,30,32,32,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.140706806,0.888429752,0.888429752,215,242,242,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.039267016,0.845070423,0.845070423,60,71,71,?a
?a  hasBiomarker  ALK_Positive  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.888888889,0.888888889,16,18,18,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Negative,0.132853403,0.838842975,0.838842975,203,242,242,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.027486911,0.913043478,0.913043478,42,46,46,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.943396226,0.943396226,50,53,53,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.038612565,0.855072464,0.855072464,59,69,69,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.054973822,0.857142857,0.857142857,84,98,98,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.02552356,0.906976744,0.906976744,39,43,43,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022905759,0.853658537,0.853658537,35,41,41,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.056282723,0.868686869,0.868686869,86,99,99,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.034031414,0.852459016,0.852459016,52,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.034685864,0.868852459,0.868852459,53,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.039267016,0.895522388,0.895522388,60,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.87804878,0.87804878,36,41,41,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.10013089,0.85,0.85,153,180,180,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.053010471,0.870967742,0.870967742,81,93,93,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.019633508,0.882352941,0.882352941,30,34,34,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.028795812,0.916666667,0.916666667,44,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.058900524,0.891089109,0.891089109,90,101,101,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.028795812,0.721311475,0.721311475,44,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.941176471,0.941176471,16,17,17,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.013089005,0.952380952,0.952380952,20,21,21,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.079188482,0.852112676,0.852112676,121,142,142,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.102748691,0.912790698,0.912790698,157,172,172,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.019633508,0.909090909,0.909090909,30,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.012434555,0.703703704,0.703703704,19,27,27,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.02552356,0.906976744,0.906976744,39,43,43,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.012434555,0.904761905,0.904761905,19,21,21,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.018979058,0.90625,0.90625,29,32,32,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.054319372,0.421319797,0.805825243,83,197,103,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.038612565,0.34502924,0.867647059,59,171,68,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.20661157,0.78125,50,242,64,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.641025641,0.961538462,25,39,26,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.132198953,0.301943199,0.762264151,202,669,265,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.09882199,0.426553672,0.766497462,151,354,197,?a
?a  hasGender  Female  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.040575916,0.356321839,0.826666667,62,174,75,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.339622642,0.837209302,36,106,43,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.019633508,0.172413793,0.882352941,30,174,34,?a
?a  hasGender  Female  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.431034483,0.78125,25,58,32,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.029450262,0.3,0.803571429,45,150,56,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.35483871,0.76744186,33,93,43,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.058246073,0.497206704,0.87254902,89,179,102,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.02486911,0.339285714,0.775510204,38,112,49,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.073298429,0.722580645,0.896,112,155,125,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.030104712,0.676470588,0.821428571,46,68,56,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.294736842,0.736842105,28,95,38,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.328571429,0.766666667,23,70,30,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.012434555,0.31147541,0.791666667,19,61,24,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.358695652,0.76744186,33,92,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.958333333,0.958333333,23,24,24,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.013743455,0.446808511,0.84,21,47,25,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.013089005,0.769230769,0.833333333,20,26,24,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.026832461,0.465909091,0.732142857,41,88,56,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.595744681,0.777777778,28,47,36,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.326530612,0.8,16,49,20,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.020942408,0.780487805,0.842105263,32,41,38,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.02617801,0.784313725,0.888888889,40,51,45,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.942857143,0.942857143,33,35,35,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.020287958,0.352272727,0.738095238,31,88,42,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.058246073,0.514450867,0.787610619,89,173,113,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.892857143,0.892857143,50,56,56,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.734693878,0.765957447,36,49,47,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.862068966,0.862068966,25,29,29,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.052356021,0.816326531,0.842105263,80,98,95,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.017015707,0.577777778,0.764705882,26,45,34,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.034685864,0.313609467,0.736111111,53,169,72,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.060863874,0.453658537,0.732283465,93,205,127,?a
?a  hasStage  IIIA  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.02617801,0.36036036,0.769230769,40,111,52,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.040575916,0.340659341,0.784810127,62,182,79,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.012434555,0.287878788,0.95,19,66,20,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.035994764,0.433070866,0.774647887,55,127,71,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.4,0.790697674,34,85,43,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.014397906,0.372881356,0.785714286,22,59,28,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.4,0.842105263,16,40,19,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.510204082,0.735294118,25,49,34,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.666666667,0.941176471,16,24,17,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.618181818,0.739130435,34,55,46,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.016361257,0.284090909,0.892857143,25,88,28,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.037958115,0.90625,0.90625,58,64,64,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.094895288,0.873493976,0.873493976,145,166,166,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.013743455,0.538461538,0.777777778,21,39,27,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.020287958,0.885714286,0.885714286,31,35,35,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.017015707,0.866666667,0.866666667,26,30,30,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.022905759,0.875,0.875,35,40,40,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.030759162,0.87037037,0.87037037,47,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.971428571,0.971428571,34,35,35,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.041884817,0.876712329,0.876712329,64,73,73,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.064790576,0.868421053,0.868421053,99,114,114,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.048429319,0.891566265,0.891566265,74,83,83,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.046465969,0.91025641,0.91025641,71,78,78,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.020942408,0.888888889,0.888888889,32,36,36,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.053010471,0.288256228,0.736363636,81,281,110,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.034031414,0.319018405,0.8125,52,163,64,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.018979058,0.966666667,0.966666667,29,30,30,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.034031414,0.912280702,0.912280702,52,57,57,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.916666667,0.916666667,33,36,36,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.02421466,0.685185185,0.822222222,37,54,45,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.064136126,0.882882883,0.882882883,98,111,111,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.015706806,0.923076923,0.923076923,24,26,26,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.041884817,0.914285714,0.914285714,64,70,70,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.02421466,0.25170068,0.711538462,37,147,52,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.375,0.75,36,96,48,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.041884817,0.537815126,0.719101124,64,119,89,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.089659686,0.404129794,0.756906077,137,339,181,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.035340314,0.593406593,0.739726027,54,91,73,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.013743455,0.6,0.875,21,35,24,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.04973822,0.493506494,0.835164835,76,154,91,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.02421466,0.324561404,0.725490196,37,114,51,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.363636364,0.777777778,28,77,36,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.04908377,0.376884422,0.735294118,75,199,102,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.029450262,0.775862069,0.865384615,45,58,52,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.068717277,0.709459459,0.846774194,105,148,124,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.373134328,0.735294118,50,134,68,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.761904762,0.8,16,21,20,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.015052356,0.5,0.851851852,23,46,27,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.015706806,0.461538462,0.827586207,24,52,29,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.041230366,0.377245509,0.768292683,63,167,82,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011780105,0.486486486,0.857142857,18,37,21,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.020942408,0.336842105,0.761904762,32,95,42,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.018979058,0.397260274,0.828571429,29,73,35,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.018324607,0.528301887,0.875,28,53,32,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.02486911,0.387755102,0.775510204,38,98,49,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.347222222,0.735294118,50,144,68,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.013089005,0.606060606,0.952380952,20,33,21,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.027486911,0.724137931,0.84,42,58,50,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.026832461,0.330645161,0.759259259,41,124,54,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.015706806,0.571428571,0.727272727,24,42,33,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.026832461,0.405940594,0.732142857,41,101,56,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.019633508,0.517241379,0.833333333,30,58,36,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011780105,0.666666667,0.857142857,18,27,21,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.010471204,0.592592593,0.842105263,16,27,19,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.666666667,0.85,34,51,40,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.013089005,0.4,0.769230769,20,50,26,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.023560209,0.342857143,0.734693878,36,105,49,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.018979058,0.298969072,0.725,29,97,40,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.388235294,0.733333333,33,85,45,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.028795812,0.392857143,0.733333333,44,112,60,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.34375,0.785714286,33,96,42,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.011125654,0.34,0.80952381,17,50,21,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.05039267,0.58778626,0.819148936,77,131,94,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.021596859,0.392857143,0.804878049,33,84,41,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.02486911,0.76,0.95,38,50,40,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.092931937,0.713567839,0.825581395,142,199,172,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.032722513,0.714285714,0.847457627,50,70,59,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022251309,0.53968254,0.772727273,34,63,44,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.037303665,0.558823529,0.76,57,102,75,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.015706806,0.615384615,0.857142857,24,39,28,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.02486911,0.716981132,0.904761905,38,53,42,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.031413613,0.428571429,0.786885246,48,112,61,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.02421466,0.660714286,0.860465116,37,56,43,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.057591623,0.435643564,0.739495798,88,202,119,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.047774869,0.760416667,0.890243902,73,96,82,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.030104712,0.547619048,0.867924528,46,84,53,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.012434555,0.612903226,0.791666667,19,31,24,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.019633508,0.731707317,0.731707317,30,41,41,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.018324607,0.8,0.8,28,35,35,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.012434555,0.487179487,0.730769231,19,39,26,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.011780105,0.514285714,0.75,18,35,24,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.013743455,0.617647059,0.7,21,34,30,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.010471204,0.761904762,0.761904762,16,21,21,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.016361257,0.641025641,0.78125,25,39,32,?a
